Spatial distribution of ultrasound targeted microbubble destruction increases cardiac transgene expression but not capillary permeability.
Ultrasound targeted microbubble destruction (UTMD) has evolved as a promising tool for organ specific gene and drug delivery. Using DNA-loaded microbubbles, cardiac transfection has been shown to be feasible. However, two-dimensional properties of the ultrasound beam limit cardiac transgene expression to the focal zone, thus, reducing its potential therapeutic effect. The aim of this study was to test if spatial distribution of ultrasound targeted microbubble destruction in the heart could lead to augmented transgene expression or increased capillary permeability. Lipid microbubbles containing plasmids with a luciferase transgene were used to target rat hearts. The diagnostic ultrasound probe was fixed in a mid-short axis view with a gel stand-off between the chest and probe. Ultrasound (1.3 MHz) with a mechanical index of 1.6 was intermittently applied to rats during microbubble infusion. Rats were randomized to either stay in that position or move horizontally in a cranio-caudal direction (3 mm sweep) relative to the ultrasound probe during UTMD. After 4 days, organs were harvested and analyzed for reporter gene expression. Another group of rats received Evans Blue, followed by UTMD with unloaded microbubbles. Again, rats were randomized into a static or moving group. Hearts were harvested to evaluate extravasation of Evans Blue. Moving rats in a cranio-caudal direction significantly increased transgene expression by 19-fold in the anterior heart, by sixfold in the posterior heart and by 32-fold in the apex. Interestingly, Evans Blue extravasation was not augmented in the moving group. Spatial distribution of UTMD may increase transgene expression due to sonication of larger areas in the heart. In contrast, capillary permeability does not increase, indicating less capillary damage.
Geis
Nicolas A
NA
Internal Medicine III, University of Heidelberg, Heidelberg 69120, Germany.
Mayer
Christian R
CR
Kroll
Richard D
RD
Hardt
Stefan E
SE
Katus
Hugo A
HA
Bekeredjian
Raffi
R
D000818:Animals; D002199:Capillary Permeability; D004396:Coloring Agents / Q000493:pharmacokinetics; D005070:Evans Blue / Q000493:pharmacokinetics; D005786:Gene Expression Regulation; D018014:Gene Transfer Techniques; D015316:Genetic Therapy / Q000379:methods; D006321:Heart / Q000033:anatomy & histology; D045423:Microbubbles; D009206:Myocardium / Q000378:metabolism*; D011897:Random Allocation; D051381:Rats; D013010:Sonication / Q000295:instrumentation / Q000379:methods*; D019076:Transgenes
D004396:Coloring Agents; D005070:Evans Blue